Addiction Medicine Board Exam Preparation Track (2020)

The Board Exam Preparation Track is designed for physicians taking the Addiction Medicine Board Exam from the American Board of Preventive Medicine.

  • A goal is to improve pass rates by helping test takers focus on high-yield concepts and successful study methods.
  • Presented in question and video format for maximum retention.
  • Topics not covered in presentations will be identified.

It consists of:

  • Video presentations from the 2020's Board Exam Review Track (7.25 CME credits). Expert presenters outline key material and board-style questions on topics covered on the exam, test taking and study tips. Following recommendations from last year's test-takers, questions on Preventive Medicine were covered in greater depth this year. The material is ordered by topic and all questions feature references and explanatory notes. 

PRICE: $450 (Members) | $600 (Non-Members)

Target Audience

  1. Those planning on taking the ABPM Addiction Medicine Board Exam. 
  2. Physicians and other clinicians who wish to conduct a self assessment of their knowledge of addiction medicine in order to identify areas for further study.

Learning Objectives

This course is designed to assist learners in assessing their competence in subject areas that comprise addiction medicine, and plan further study as needed.

Course summary
Available credit: 
  • 7.25 AMA Category 1
  • 7.25 Attendance
Course opens: 
09/11/2020
Course expires: 
09/11/2023
Cost:
$600.00
  1. Introduction | Mason Turner, MD
  2. Social Science | Dustin DeYoung, MD
  3. Club Drugs/Hallucinogens | Marie Muligan, MD
  4. Pregnancy and Preventive Medicine | Deborah Stephenson, MD
  5. Adolescents/Special Topics | Mason Turner, MD
  6. Basic Science | Thomas Meeks, MD
  7. Opioids and Pain | Thomas Meeks, MD
  8. Alcohol | John Tsuang, MD
  9. Dual Diagnosis | John Tsuang, MD
  10. Cannabis | Marie Mulligan, MD
  11. Medical Presentations | Triveni DeFries, MD
  12. Sedative Hypnotics | Angie Chen, MD

Chwen-Yuen Angie Chen, MD, FACP, FASAM, Co-Chair
Dr. Chen is currently Medical Director of Chemical Dependency Clinics in Primary Care at Stanford University. She is a board member of CSAM as chair of communications, Editor of the CSAM newsletter, and oversees the Test Taking Track Board Review Question Bank.
No relevant financial relationships to disclose.

Triveni DeFries, MD
Dr. DeFries is an Assistant Clinical Professor of Medicine at UCSF in the Department of Internal Medicine. She serves as the Associate Medical Director of the general internal medicine clinic at San Francisco General Hospital.
No relevant financial relationships to disclose.

Dustin DeYoung, MD
Dr. DeYoung, MD, is a psychiatrist for the University of California, Los Angeles (UCLA) Behavioral Health Associates and a research physician for the UCLA Department of Family Medicine.
Disclosure: BDH Pharma, LLC: Ownership Interest (stocks, stock options, or other ownership interest excluding diversified mutual funds)

Thomas W. Meeks, MD, FASAM
Dr. Meeks is Medical Director of the Addiction Recovery Treatment Services at the Sacramento VA Medical Center and Assistant Clinical Professor of Psychiatry at UC Davis.
No relevant financial relationships to disclose.

Marie A. Mulligan, MD
Dr. Mulligan has provided primary care to patients living with substance use disorders and their family members for more than twenty years. She worked at SRCH since 2006 providing primary care to primarily Spanish speaking and English-speaking patients, including those living with severe mental illness and homelessness.
No relevant financial relationships to disclose.

Deborah Stephenson, MD
Dr. Stephenson is boarded in Preventive Medicine & Public Health, and Addiction Medicine through the American Board of Addiction Medicine. She works as a Senior Staff Physician managing patients with opioid use disorder in an ambulatory care clinic, which houses an Opioid Treatment Program, a Perinatal Substance Abuse Program and a Medication Assisted Treatment program.
No relevant financial relationships to disclose.

John Tsuang, MD, MS
Dr. Tsuang is the director of the Dual Diagnosis Treatment Program at the Harbor/UCLA Medical Center. He is a Clinical Professor of Psychiatry at the UCLA School of Medicine.
No relevant financial relationships to disclose.

Mason Turner, MD, MS, Co-Chair
Mason Turner, MD, is a psychiatrist at the Maui Lani Medical Office. He served as director of outpatient mental health and addiction medicine for Kaiser Permanente Northern California.
No relevant financial relationships to disclose.

CREDIT

PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians.  CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.

CSAM designates this educational activity/enduring material for a maximum of 7.25 AMA/PRA Category 1 Credits. (Physicians should only claim credit commensurate with the extent of their participation in the activity.) This credit may also be applied to the CMA Certification in Continuing Medical Education.

NON-PHYSICIANS: The California Society of Addiction Medicine (CSAM) provides a certificate of attendance for this online course based upon the number of hours you participated, up to maximum of 7.25. 

MAINTENANCE OF CERTIFICATION (MOC)

ABAM
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification (tMOC) Program can apply a maximum of 7.25 AMA PRA Category 1 Credits™ for completing the Board Exam Preparation Track.
Users are responsible for reporting CME credits directly to ABAM.

ABIM
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
CSAM will report your participation to ABIM at the end of the year.

ABPM
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 7.25 LLSA credits towards ABPM MOC Part II requirements. Complete the webform.
Users are responsible for reporting CME credits directly to ABPM.

Available Credit

  • 7.25 AMA Category 1
  • 7.25 Attendance

Price

Cost:
$600.00
Please login or register to take this course.